Physicians' Academy for Cardiovascular Education

Are new Incretin-based treatments changing the fundamentals of diabetes management?

Lecture - Nov. 6, 2016 - Seoul, Korea - Prof. Sanjay Rajagopalan, MD Cleveland, OH, USA - CDMC 2016 Seoul

This lecture was part of a Cardio Diabetes Master Class 'Contemporary issues in T2DM & cardiovascular risk: Review of latest insights for optimizing patient management' held on November 5-6 2016 in Seoul Korea

Educational information

The educational objectives of this Cardio Diabetes Master Class were:

CME accreditation

The Cardio Diabetes Master Class was accredited by the European Board for Accreditation in Cardiology (EBAC) for 9 CME credit hours

Disclosures

Prof Sanjay Rajagopalan, MD, FACC, FAHA is Chief, Cardiovascular Medicine, Herman Hellerstein Chair of Cardiovascular Research Director, Cardiovascular Research Institute - Professor of Medicine, Case Western Reserve School of Medicine, Cleveland, OH, USA

Funding

The master class is supported by an unrestricted educational grant provided by Takeda Pharmaceuticals

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.

Share this page with your colleagues and friends: